Autoimmune rheumatic diseases are systemic diseases frequently affecting the heart and vessels. The main cardiovascular complications are pericarditis, myocarditis, valvular disease, obstructive coronary artery disease and coronary microcirculatory dysfunction, cardiac failure and pulmonary hypertension. Echocardiography, including transthoracic two and three-dimensional echocardiography, Doppler imaging, myocardial deformation and transesophageal echo, is an established and widely available imaging technique for the identification of cardiovascular manifestations that are crucial for prognosis in rheumatic diseases. Echocardiography is also important for monitoring the impact of drug treatment on cardiac function, coronary microcirculatory function, valvular function and pulmonary artery pressures. In this article we summarize established and evolving knowledge on the role of echocardiography for diagnosis and prognosis of cardiovascular abnormalities in rheumatic diseases.
CITATION STYLE
Makavos, G., Varoudi, M., Papangelopoulou, K., Kapniari, E., Plotas, P., Ikonomidis, I., & Papadavid, E. (2020, September 1). Echocardiography in autoimmune rheumatic diseases for diagnosis and prognosis of cardiovascular complications. Medicina (Lithuania). MDPI AG. https://doi.org/10.3390/medicina56090445
Mendeley helps you to discover research relevant for your work.